Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Income towards Parent Company: 2010-2025

Historic Income towards Parent Company for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Sep 2025 value amounting to $40.1 million.

  • Ironwood Pharmaceuticals' Income towards Parent Company rose 999.29% to $40.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $130.5 million, marking a year-over-year increase of 156.81%. This contributed to the annual value of $102.8 million for FY2024, which is 108.17% up from last year.
  • According to the latest figures from Q3 2025, Ironwood Pharmaceuticals' Income towards Parent Company is $40.1 million, which was up 69.84% from $23.6 million recorded in Q2 2025.
  • Ironwood Pharmaceuticals' Income towards Parent Company's 5-year high stood at $391.3 million during Q2 2021, with a 5-year trough of -$1.1 billion in Q2 2023.
  • Over the past 3 years, Ironwood Pharmaceuticals' median Income towards Parent Company value was $3.6 million (recorded in 2024), while the average stood at -$102.6 million.
  • In the last 5 years, Ironwood Pharmaceuticals' Income towards Parent Company tumbled by 3,038.30% in 2023 and then spiked by 2,844.07% in 2025.
  • Over the past 5 years, Ironwood Pharmaceuticals' Income towards Parent Company (Quarterly) stood at $41.4 million in 2021, then rose by 18.16% to $48.9 million in 2022, then crashed by 567.15% to -$228.3 million in 2023, then soared by 145.63% to $104.2 million in 2024, then soared by 999.29% to $40.1 million in 2025.
  • Its Income towards Parent Company stands at $40.1 million for Q3 2025, versus $23.6 million for Q2 2025 and -$37.4 million for Q1 2025.